PRAXAIR INC|4Nov 7, 11:46 AM ET

PRAXAIR INC 4

4 · PRAXAIR INC · Filed Nov 7, 2014

Form 4

Period: 2014-11-06

Senior VP, Gen. Counsel & Sec.

Transactions

Exercise/Conversion
Common Stock
2014-11-06$60.92/sh+4,120$250,990→ 41,944 total
Sale
Common Stock
2014-11-06$126.52/sh−4,120$521,262→ 37,824 total
Exercise/Conversion
Stock Option (right to buy)
2014-11-06−4,120→ 0 total
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (4,120 underlying)

Holdings

Common Stock
(indirect: By 401(k))
5,715.408
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (39,300 underlying)
39,300
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (16,960 underlying)
16,960
Stock Option (right to buy)
Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (37,930 underlying)
37,930
Stock Option (right to buy)
Exercise: $110.58From: 2014-02-26Exp: 2023-02-26→ Common Stock (29,755 underlying)
29,755
Stock Option (right to buy)
Exercise: $128.80From: 2015-02-25Exp: 2024-02-25→ Common Stock (31,090 underlying)
31,090
Stock Option (right to buy)
Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (36,095 underlying)
36,095
Deferred Stock
Exercise: $0.00→ Common Stock (1,383.773 underlying)
1,383.773

Footnotes (7)

[F1]The $126.52 price reported is the weighted average sale price. The sale prices ranged from $126.508 to $126.524 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
[F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
[F3]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
[F4]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
[F5]This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
[F6]Conversion to Praxair Common Stock is on a 1-for-1 basis.
[F7]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.

Documents

1 file